Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease is a research paper published in Molecular & Cellular Proteomics (2023). On theSindex it has a DataRank of 0. It has been cited 62 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS
Grant: T32 NS061788
National Institute on Aging
Grant: P30AG10161
National Institute on Aging
Grant: AG068024
National Institute on Aging
Grant: AG054719
National Institute on Aging
Grant: U01AG061357
National Institute on Aging
Grant: AG063755
National Institute on Aging
Grant: P30AG72975
National Institute on Aging
Grant: R01AG061800
National Institute on Aging
Grant: R01AG17917
National Institute on Aging
Grant: R01AG15819
National Institute on Aging
Grant: U01AG46152
National Institute on Aging
Grant: U01AG61356
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 5U01AG061357-05
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers
National Institutes of Health
Grant: 5R01AG054719-03
Targeting Rho Kinases for Alzheimer's disease Therapeutics
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5R01AG061800-04
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
National Institutes of Health
Grant: 5T32NS061788-10
Training Program In The Neurobiology Of Cognition And Cognitive Disorders
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 7U01AG046152-05
Pathway discovery, validation and compound identification for Alzheimer's disease
National Institutes of Health
Grant: 5P30AG072975-02
Rush Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG015819-07
Risk Factors, Pathology, and Clinical Expressions of AD
Fields of Study
Keywords